|
|
Volumn 1, Issue 1, 1999, Pages 47-53
|
|
Systemic therapy for advanced or recurrent endometrial carcinoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER STAGING;
CARCINOMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
ENDOMETRIUM TUMOR;
FEMALE;
HOSPITALIZATION;
HUMAN;
MORTALITY;
PATHOLOGY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
CARCINOMA;
DISEASE-FREE SURVIVAL;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
SEVERITY OF ILLNESS INDEX;
SURVIVAL ANALYSIS;
|
|
EID: 0033188047
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-999-0009-3 Document Type: Review |
|
Times cited : (8)
|
|
References (49)
|
